These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes. Faist F; Short S; Kneale GG; Sharpe CR Biosci Rep; 2009 Jun; 29(3):143-9. PubMed ID: 18752469 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptors as therapeutic targets in the management of liver diseases. Mallat A; Lotersztajn S Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549 [TBL] [Abstract][Full Text] [Related]
13. On fluoro-18 labeling of bile acids. Frisch K; Sørensen M Nucl Med Biol; 2014 Oct; 41(9):775. PubMed ID: 25108377 [No Abstract] [Full Text] [Related]
14. miR-122, a paradigm for the role of microRNAs in the liver. Girard M; Jacquemin E; Munnich A; Lyonnet S; Henrion-Caude A J Hepatol; 2008 Apr; 48(4):648-56. PubMed ID: 18291553 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors and adaptor molecules in liver disease: update. Seki E; Brenner DA Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843 [TBL] [Abstract][Full Text] [Related]
16. Improvement of liver stem cell engraftment by protein delivery. Exp Biol Med (Maywood); 2009 Sep; 234(9):vi. PubMed ID: 19704070 [No Abstract] [Full Text] [Related]
17. Detecting ligands and dissecting nuclear receptor-signaling pathways using recombinant strains of the yeast Saccharomyces cerevisiae. Fox JE; Burow ME; McLachlan JA; Miller CA Nat Protoc; 2008; 3(4):637-45. PubMed ID: 18388946 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB signaling, liver disease and hepatoprotective agents. Sun B; Karin M Oncogene; 2008 Oct; 27(48):6228-44. PubMed ID: 18931690 [TBL] [Abstract][Full Text] [Related]